Advertisement
Clinical Investigation
JAMA. 1983;249(2):237-241. doi: 10.1001/jama.1983.03330260055032

Response of Thiazide-lnduced Hypokalemia to Amiloride

  1. Robert F. Maronde, MD;
  2. Mildred Milgrom, MD;
  3. Nicolas D. Vlachakis, MD;
  4. Linda Chan, PhD
  1. From the Clinical Pharmacology Section, Department of Medicine, University of Southern California School of Medicine (Drs Maronde, Milgrom, and Vlachakis), and the Los Angeles County/University of Southern California Medical Center (Dr Chan), Los Angeles.

Abstract

The effects of amiloride hydrochloride on thiazide-induced hypokalemia were evaluated. In metabolic balance studies, amiloride reversed thiazide-induced urinary potassium loss, restored plasma bicarbonate concentration and pH to pretreatment levels, and produced further increases in aldosterone secretion. Effects of long-term administration of hydrochlorothiazide and an amiloride-hydrochlorothiazide combination were compared in outpatients who had experienced thiazide-induced hypokalemia while receiving oral potassium supplements. After eight weeks, those given hydrochlorothiazide alone had an average serum potassium level of 3.01± 0.10 (SD) mEq/L, significantly lower than the control level (3.75 ±0.08 mEq/L). Those given the amiloride-hydrochlorothiazide combination had an average serum potassium level of 3.75 ±0.08 mEq/L, not significantly different from the control value (3.82 ±0.08 mEq/L). Both groups had increased plasma aldosterone concentrations and plasma renin activity. The potassium-conserving effect of amiloride persisted with extended therapy.

(JAMA 1983;249:237-241)

Footnotes

  • Reprint requests to Clinical Pharmacology Section, University of Southern California School of Medicine, 2025 Zonal Ave, Los Angeles, CA 90033 (Dr Maronde).

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals